SUSAN DUMIRE: Open Payments
NPI 1285230169 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 12 payments from 6 companies in 2025. Trend: 2023 $741 · 2024 $1,079 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $140 |
| Alkermes, Inc. | 4 | $93 |
| ABBVIE INC. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: INGREZZA, ARISTADA, VRAYLAR, CAPLYTA, Auvelity, COBENFY.
Industry payments across NC — which companies pay providers there.
